2022
Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review
Bandeira ID, Lins-Silva DH, Cavenaghi VB, Dorea-Bandeira I, Faria-Guimarães D, Barouh JL, Jesus-Nunes AP, Beanes G, Souza LS, Leal GC, Sanacora G, Miguel EC, Sampaio AS, Quarantini LC. Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review. Harvard Review Of Psychiatry 2022, 30: 135-145. PMID: 35267254, DOI: 10.1097/hrp.0000000000000330.Peer-Reviewed Original ResearchConceptsObsessive-compulsive disorderSystematic reviewN-methyl-D-aspartate receptor antagonistAppropriate washout periodOpen-label trialPlacebo-controlled trialFirst-line treatmentRetrospective chart reviewUse of ketamineEffects of ketamineMeta-analysis protocolCombination of ketaminePubMed/MEDLINEPreferred Reporting ItemsMore effective treatmentsPotent N-methyl-d-aspartate receptor antagonistKetamine treatmentChart reviewGlutamate modulatorsGood tolerabilityReuptake inhibitorsWashout periodCase reportGlutamatergic neurotransmissionReceptor antagonistDouble cone coil repetitive transcranial magnetic stimulation for severe obsessive-compulsive disorder after reversible cerebral vasoconstriction syndrome with intracerebral hemorrhage: a case report
Silveira J, Damiano R, Abelama E, dos Santos Mosqueira Gomes R, Klein I, Borrione L, Sudbrack P, Gentil A, Shephard E, Brunoni A, Miguel E, Echevarria M. Double cone coil repetitive transcranial magnetic stimulation for severe obsessive-compulsive disorder after reversible cerebral vasoconstriction syndrome with intracerebral hemorrhage: a case report. Brazilian Journal Of Psychiatry 2022, 44: 562-564. PMID: 36423361, PMCID: PMC9561833, DOI: 10.47626/1516-4446-2022-2556.Peer-Reviewed Original Research
2014
Exaggerating, mislabeling or simulating obsessive–compulsive symptoms: Case reports of patients claiming to have obsessive–compulsive disorder
Fontenelle L, Lins-Martins N, Melca I, Lima A, de Menezes G, Torres A, Yücel M, Miguel E, Mendlowicz M. Exaggerating, mislabeling or simulating obsessive–compulsive symptoms: Case reports of patients claiming to have obsessive–compulsive disorder. Comprehensive Psychiatry 2014, 55: 1188-1194. PMID: 24794641, DOI: 10.1016/j.comppsych.2014.03.023.Peer-Reviewed Original ResearchConceptsObsessive-compulsive disorderDrug-related side effectsAxis I psychiatric disordersNon-consecutive patientsDisease courseCase reportTreatment responsePsychiatric disordersReported casesSide effectsSymptom patternsClinical judgmentOCD clinicPatientsExperienced cliniciansObsessive-compulsive symptomsPattern of responseFormal diagnosisSymptomsDiagnosisOCD diagnosisCompulsive symptomsDisordersClinicClinical vignettes
1989
Catatonic syndrome caused by autoimmune disease: spontaneous remission.
Lichtenstein A, Calish I, Oliveira R, Miguel Filho E, Rocha A. Catatonic syndrome caused by autoimmune disease: spontaneous remission. Clinics 1989, 44: 312-5. PMID: 2486424.Peer-Reviewed Original ResearchConceptsCSF immune complexesAutoimmune diseasesImmune complexesCatatonic syndromeCerebrospinal fluidPositive antinuclear factorSystemic lupus erythematosusAntinuclear factorLupus erythematosusRare manifestationSystemic involvementSystemic manifestationsSpontaneous remissionImmunosuppressive drugsPsychiatric manifestationsCatatonic patientsImmunologic testsCase reportMetabolic disturbancesPsychiatric effectsNucleolar patternSchizophrenic disordersValuable markerDiseasePsychiatric picture